Qiagen to Expand in Maryland, Add 90 Employees | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen has plans to invest around $52 million in expanding its operations at its North American headquarters in Germantown, Md., according to a statement released yesterday by Maryland Governor Martin O'Malley.

The firm intends to add 90 full-time positions in connection with the expansion by 2015, as well as 117,000 square feet of new manufacturing and office space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.